Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo

Schreckenberg, RolfRolfSchreckenbergWolf, AnnemarieAnnemarieWolfSzabados, TamaraTamaraSzabadosGömöri, KamillaKamillaGömöriSzabó, István AdorjánIstván AdorjánSzabóÁgoston, GergelyGergelyÁgostonBrenner, GáborGáborBrennerBencsik, PéterPéterBencsikFerdinandy, PéterPéterFerdinandySchulz, RainerRainerSchulzSchlüter, Klaus-DieterKlaus-DieterSchlüter2022-08-222022-08-222022https://jlupub.ub.uni-giessen.de/handle/jlupub/6617http://dx.doi.org/10.22029/jlupub-6068enNamensnennung 4.0 Internationalddc:610Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo